Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Eisai readies applications for thyroid cancer drug after SFJ delivers PhIII success
Eisai readies applications for thyroid cancer drug after SFJ delivers PhIII success
Eisai readies applications for thyroid cancer drug after SFJ delivers PhIII success
Submitted by
admin
on February 4, 2014 - 7:05pm
Source:
Fierce Biotech
News Tags:
Eisai
Lenvatinib
thyroid cancer
SFJ Pharmaceuticals
Headline:
Eisai readies applications for thyroid cancer drug after SFJ delivers PhIII success
Do Not Allow Advertisers to Use My Personal information
